This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Pandemic lockdowns linked to sustained cognitive decline among older adults, study finds
Read more
Anastrozole indication expanded by MHRA to include breast cancer prevention
Read more
Adagrasib approved in the UK for NSCLC after earlier EU rejection
Read more
New inpatient tool for spotting deterioration in children launched by NHS England
Read more
Emergency medicine legally recognised as medical specialty in the Netherlands
Read more
Second biologic for hidradenitis suppurativa recommended by NICE
Read more
Heart failure to be covered by virtual wards, NHS England says
Read more
The ‘damning reality of emergency care’ in England outlined by MPs in new report
Read more
Trial launched to identify optimum breathing support for babies with bronchiolitis
Read more
Novel injectable bispecific antibody for advanced lymphoma receives EU and UK green light
Read more
Positive CHMP opinion for rucaparib in advanced ovarian cancer
Read more
Variation in gut microbiome a possible marker for colorectal cancer, study finds
Read more
New treatment guidelines for alcohol dependence subject to UK-wide consultation
Read more
Air pollution and antibiotic resistance: is there cause for concern?
Read more
Bispecific antibody glofitamab available on the NHS ‘within weeks‘ for advanced lymphoma
Read more
Optimising tobacco dependency services in secondary care
Read more
EADV: Improvement in AI skin cancer detection as software identifies all melanoma cases
Read more
Page 9 of 200
« First
«
...
7
8
9
10
11
...
20
30
40
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: